116 related articles for article (PubMed ID: 10561842)
21. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
[TBL] [Abstract][Full Text] [Related]
22. Pre-mRNA Splicing Modulation by Antisense Oligonucleotides.
Singh NN; Luo D; Singh RN
Methods Mol Biol; 2018; 1828():415-437. PubMed ID: 30171557
[TBL] [Abstract][Full Text] [Related]
23. Beta-thalassemia resulting from a single nucleotide substitution in an acceptor splice site.
Atweh GF; Anagnou NP; Shearin J; Forget BG; Kaufman RE
Nucleic Acids Res; 1985 Feb; 13(3):777-90. PubMed ID: 2987809
[TBL] [Abstract][Full Text] [Related]
24. Quantification analysis of splice signal sequences. Exon skipping in beta-globin gene of thalassemia.
Iida Y
Nucleic Acids Symp Ser; 1993; (29):161-2. PubMed ID: 8247751
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of zebrafish fgf8 pre-mRNA splicing with morpholino oligos: a quantifiable method for gene knockdown.
Draper BW; Morcos PA; Kimmel CB
Genesis; 2001 Jul; 30(3):154-6. PubMed ID: 11477696
[No Abstract] [Full Text] [Related]
26. Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseases.
Du L; Gatti RA
J Immunol Methods; 2011 Feb; 365(1-2):1-7. PubMed ID: 21147113
[TBL] [Abstract][Full Text] [Related]
27. Repair of a splicing defect in erythroid cells from patients with beta-thalassemia/HbE disorder.
Suwanmanee T; Sierakowska H; Fucharoen S; Kole R
Mol Ther; 2002 Dec; 6(6):718-26. PubMed ID: 12498768
[TBL] [Abstract][Full Text] [Related]
28. Differential enzymatic accessibilities of the 5' and 3' splice sites of beta-globin pre-messenger RNA in splicing competent HeLa cell nuclear extract.
Siegall CB; Kumar A
Biochem Biophys Res Commun; 1988 Jan; 150(2):517-25. PubMed ID: 2829876
[TBL] [Abstract][Full Text] [Related]
29. Antisense Oligonucleotide Design and Evaluation of Splice-Modulating Properties Using Cell-Based Assays.
Slijkerman R; Kremer H; van Wijk E
Methods Mol Biol; 2018; 1828():519-530. PubMed ID: 30171565
[TBL] [Abstract][Full Text] [Related]
30. Engineered U7 snRNA mediates sustained splicing correction in erythroid cells from β-thalassemia/HbE patients.
Preedagasamzin S; Nualkaew T; Pongrujikorn T; Jinawath N; Kole R; Fucharoen S; Jearawiriyapaisarn N; Svasti S
Biochem Biophys Res Commun; 2018 Apr; 499(1):86-92. PubMed ID: 29550480
[TBL] [Abstract][Full Text] [Related]
31. RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice.
Svasti S; Suwanmanee T; Fucharoen S; Moulton HM; Nelson MH; Maeda N; Smithies O; Kole R
Proc Natl Acad Sci U S A; 2009 Jan; 106(4):1205-10. PubMed ID: 19164558
[TBL] [Abstract][Full Text] [Related]
32. Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs.
Sazani P; Kang SH; Maier MA; Wei C; Dillman J; Summerton J; Manoharan M; Kole R
Nucleic Acids Res; 2001 Oct; 29(19):3965-74. PubMed ID: 11574678
[TBL] [Abstract][Full Text] [Related]
33. Quantification analysis of splice signal sequences: mutation of 3'-splice signal sequence and mechanism of unsplicing in a beta-thalassemia pre-mRNA.
Iida Y
Nucleic Acids Symp Ser; 1999; (42):63-4. PubMed ID: 10780380
[TBL] [Abstract][Full Text] [Related]
34. Antisense-mediated redirection of mRNA splicing.
Vacek M; Sazani P; Kole R
Cell Mol Life Sci; 2003 May; 60(5):825-33. PubMed ID: 12827272
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of pre-mRNA splicing by antisense RNA in vitro: effect of RNA containing sequences complementary to exons.
Volloch V; Schweitzer B; Rits S
Biochem Biophys Res Commun; 1991 Sep; 179(3):1593-9. PubMed ID: 1656959
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of pre-mRNA splicing by antisense RNA in vitro: effect of RNA containing sequences complementary to introns.
Volloch V; Schweitzer B; Rits S
Biochem Biophys Res Commun; 1991 Sep; 179(3):1600-5. PubMed ID: 1930200
[TBL] [Abstract][Full Text] [Related]
37. Making antisense of splicing.
Garcia-Blanco MA
Curr Opin Mol Ther; 2005 Oct; 7(5):476-82. PubMed ID: 16248283
[TBL] [Abstract][Full Text] [Related]
38. Transient transfection of HeLa cells for analysis of splicing reaction.
Aebi M
Methods Enzymol; 1990; 181():43-8. PubMed ID: 2381326
[No Abstract] [Full Text] [Related]
39. Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides.
Du L; Pollard JM; Gatti RA
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):6007-12. PubMed ID: 17389389
[TBL] [Abstract][Full Text] [Related]
40. Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes.
Marquis J; Kämpfer SS; Angehrn L; Schümperli D
Gene Ther; 2009 Jan; 16(1):70-7. PubMed ID: 18701908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
